Compare GOOS & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | GOOS | SLBT |
|---|---|---|
| Founded | 1957 | N/A |
| Country | Canada | Taiwan |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 789.1M | 644.9M |
| IPO Year | 2016 | 2025 |
| Metric | GOOS | SLBT |
|---|---|---|
| Price | $8.79 | $0.91 |
| Analyst Decision | Hold | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $9.43 | N/A |
| AVG Volume (30 Days) | ★ 893.3K | 38.2K |
| Earning Date | 11-05-2026 | 10-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.18 | N/A |
| Revenue Next Year | $4.02 | N/A |
| P/E Ratio | $75.22 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.36 | $1.02 |
| 52 Week High | $14.60 | $6.25 |
| Indicator | GOOS | SLBT |
|---|---|---|
| Relative Strength Index (RSI) | 71.10 | 26.53 |
| Support Level | $8.75 | N/A |
| Resistance Level | $10.42 | $1.75 |
| Average True Range (ATR) | 0.35 | 0.17 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 75.27 | 25.12 |
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale; Direct to Consumer (DTC), and Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia-Pacific, and Europe, the Middle East, and Africa.
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.